Abstract: We report a clinical strain of Enterobacter cloacae, PIMB10EC27, isolated in Vietnam in 2010 that was resistant to 21 of 26 tested antibiotics, including carbapenems (MICs >64 µg/mL) and colistin (MIC >128 µg/mL). The complete genome of strain PIMB10EC27 was sequenced by PacBio RSII and the Illumina Miseq system. Whole-genome analysis revealed that PIMB10EC27 contains a chromosome of the ST513 group (PIMBEC27, length 5,272,177 bp) and two plasmids, pEC27-1 of the IncX3 group (length 62,470 bp) and pEC27-2 of the IncHI1 group (length 84,602 bp). It also revealed that strain PIMB10EC27 carries 15 genes that confer resistance to at least 10 antibiotic groups. Particularly, the insertion of ISKpn19 and Tn6901 into the genomic context of bla NDM-1 was first identified and described. In another context, amino acid mutations G273D in PmrB and F515S in PmrC were first identified on the chromosome of PIMB10EC27, which may confer resistance to colistin in this strain.
Carbapenems are one of the broad-spectrum groups of β-lactam antibiotics and have been considered the best choice for treatment of infections caused by multidrug-resistant bacteria, 1 however, the recent increase in the rate of carbapenem resistance has been a cause for concern. 2 Encoded by the bla NDM-1 gene, New Delhi metallo-β-lactamase 1 (NDM-1), one of the most active and transmissible carbapenemases among the carbapenem-hydrolyzing β-lactamases, was first characterized by Yong et al in 2009 3 and has rapidly spread globally. To date, at least 17 NDM alleles have been characterized 4 and the Tn125 composite transposon bracketed by two copies of ISAba125 appears to be the main vehicle for dissemination of the bla NDM-1 gene. 5 The lack of new generations of antibiotics has positioned colistin, a decades-old antibiotic, as one of the treatments of last resort against multidrugresistant bacteria, particularly carbapenem-resistant Gram-negative bacteria. 6, 7 Unfortunately, colistin resistance has been reported and is increasing. [8] [9] [10] [11] Enterobacter cloacae belongs to the Enterobacteriaceae family. These Gramnegative bacteria have been a frequent cause of nosocomial multidrug-resistant bacterial infections in the last decade. 12, 13 Carbapenem-resistant E. cloacae has been commonly reported in Vietnam and many other countries in the world. [14] [15] [16] However, colistin resistance in E. cloacae has not been reported widely, particularly carbapenemaseproducing colistin-resistant E. cloacae has very recently been reported from some countries including India, 10 the United States, 17 and China. In this study, the whole genome of a clinical carbapenemand colistin-resistant E. cloacae strain, PIMB10EC27, was sequenced and analyzed for its genetic characteristics that may associate with its resistance phenotypes.
PIMB10EC27 was recovered from the urine of a 72-year-old male patient admitted to Binh Dan Hospital in Vietnam in December 2010 with diagnoses of invasive prostate cancer and urosepsis, he had undergone prostatectomy at the same hospital 15 days earlier. The patient was discharged at the request of the family in a state of acute urinary retention and respiratory failure 4 days after hospitalization. During hospitalization, the patient was treated with meropenem, cefoperazone, sulbactam, clavulanic acid, and amoxicillin, but not with colistin. The strain was isolated as a part of the routine hospital laboratory procedures and identified as E. cloacae using a Vitek II kit (BioMérieux, USA).
The in vitro antibiotic susceptibility of PIMB10EC27 was tested by the Kirby-Bauer (KB) method, and the minimum inhibitory concentration (MIC) using the agar dilution method was also determined according to recommendations of the Clinical and Laboratory Standards Institute (CLSI 2018) 19 except for colistin, which was performed with broth microdilution method and interpreted by the guidelines of European Union Committee for Antimicrobial Susceptibility Testing (EUCAST 2019). 20 The results showed that PIMB10EC27 was resistant to 21 of 26 tested antibiotics, particularly imipenem (MIC >64 µg/mL), ertapenem (MIC =128 µg/mL), meropenem (MIC =128 µg/mL), and colistin (MIC >128 µg/mL); susceptible to amikacin, levofloxacin nitrofurantoin; and showed intermediate resistance to ciprofloxacin, oxfloxacin (Table 1) . A Nextera XT DNA Library Prep Kit (Illumina Inc., USA) and SMRTbell Template Prep Kit (Pacific Biosciences, USA) were used to prepare libraries for the whole genome sequencing of PIMB10EC27 using simultaneously the MiSeq System (Illumina Inc.) with MiSeq Reagent Kit v.2 (2×150 cycles), and the PacBio RSII (Pacific Biosciences) together with Sequel Sequencing Kit 2.0 (8 rxn).
In total, 3.8Gb of filtered subreads were obtained from PacBio RSII sequencing platform. Using PacBio's prepatching program, we obtained 353Mb of 35,932 reads with the sizes of 500-27,847 bp. The pre-assemble reads were further packaged with HGAP program, which yielded a 5,272,177 bp chromosome and two plasmids of 62,318 bp and 84,480 bp. MiSeq data was used for the error correction of PacBio consensus sequences. By integrating these two platforms, we were able to obtain the complete genome which consisted of a chromosome (5,272,177 bp) belonging to the ST513 group and two plasmids, pEC27-1 of the IncX3 group (62,470 bp) and pEC27-2 of the IncHI1 group (84,602 bp) ( Figure 1 ). The complete genome sequence was annotated with NCBI Prokaryotic Genome Annotation Pipeline servers and analyzed by bioinformatics programs or software, including ResFinder 2.1, 21 MLST, 22 Isaga, 23 Galaxy, 24 and Plasmid Finder 25 for antibiotic resistance genes identification, chromosome classification, sequences of insertion sequence (IS) determination, integrons finding, and plasmids classification, respectively. In total, 15 coding genes conferring resistance to 10 antibiotic groups were found on PIMB10EC27 (Table 2) . Among these genes, bla NDM-1 , bla SHV-12 , bla CMH , aac (3)-ID , strA, strB, dfrA-14, sul2, catA2, and tet(D) were associated with resistance open reading frames (tORFs) were identified in which the number of tORFs located on the chromosome, pEC27-1 and pEC27-2 were 113, 10 and 37, respectively. Antibiotic resistance genes closely located to these transposase sequences may have contributed to the accumulation and increase in the antibiotic resistance of PIMB10EC27. A 1722-bp class 1 integron with gene cassette dfrA14 flanked by IS6 sequences was also found on plasmid pEC27-2. We further analyzed the genes in PIMB10EC27 that confer resistance to carbapenem and colistin. As a result, a bla NDM-1 gene was found on pEC27-1 of PIMB10EC27 along with a bla SHV-12 and ble MBL . A comparison of the nucleotide sequence of pEC27-1 and those of other IncX3 plasmids carrying bla NDM-1 and bla SHV-12 , including pKPN5047 (KC311431), pNDM-HF727 (KF976405), pNDM-HN380 (JX104760), and RJA274 plasmid NDM-1 (KF877335) was carried out in order to identify if any unique structure characteristics contributed to the multidrugresistance of PIMB10EC27. Comparative results of the genomic context surrounding the resistance genes revealed that all of the plasmids had a conserved sequence carrying ΔISAba125, bla NDM-1 , ble MBL , trpF, dsbC, cutA1, groES, groEL, and ISCR21 (Figure 2 ). This conserved sequence is also a Tn125 composite transposon, in which the bla NDM-1 gene lies downstream of a truncated ISAba125 element that provides the −35 region for the promoter of bla NDM-1.
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A 93-bp sequence separates the right-hand inverted repeat of ISAba125 from the start codon of bla NDM-1 , and the deletion of an IS5 was identified in the plasmid pEC27-1. An ISCR21-like element was also found downstream of bla NDM-1 and it is suggested that this element may be responsible for initial gene capture. 5 The IS26-bounded region of pEC27-1 containing ygbI, ygbJ, and bla SHV-12 was found to be very distinct from the other plasmids. This region carried three copies of IS26, and the local ygbJ gene was split into two parts, whereas other plasmids carried only two copies of IS26 and the full ygbJ gene. The isolation and reverse with a copy of IS26 in the plasmid pEC27-1 of the 424-bp region of the ygbJ gene might propose there is an IS26-mediated re-organization. Interestingly, an insertion of ISKpn19 and Tn6901 into the mpr gene (encoding zinc metalloproteinase) lying further upstream of bla NDM-1 was also observed (Figure 2 ). Belonging to ISKra4 family, ISKpn19 is 2851 bp in length and has been found to lie downstream of bla OXA-181 in an IncX3-type plasmid.
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Tn6901, first described in plasmid Rts1 of Proteus vulgaris, 31 is 6.9 kb in length and harbors 6 genes, including a transposase gene (tnpA), a resolvase gene (tnpR), an alcohol dehydrogenase gene (adh), a glyoxalase/bleomycin resistance gene (glo), an S-formylglutathione hydrolase gene (fgh), and a regulatory protein gene (frmR). We report here the first case, to our knowledge, of a 9.8-kb insertion sequence harboring ISKpn19 and Tn6901 in the genomic Figure 2 Genetic context of bla NDM-1 on IncX3 plasmids pKPN5047, pNDM-HF727, pNDM-HN380, RJA274 plasmid NDM-1, and pEC27-1. Gray shading denotes shared regions of homology: light gray indicates a forward match and dark gray indicates a reverse match. Notably, ygbJ is split into two parts, and the IS26-ΔygbJ region is inverted in pEC27-1 relative to the other plasmids. The mpr gene in pEC27-1 is interrupted by ISKpn19 and Tn6901 insertions. Open reading frames are portrayed by arrows and are colored. Resistance genes are indicated in red arrows, including bla NDM-1 , bla SHV-12 , ble MBL , fgh, glo, and adh. context of bla NDM-1. This insertion made the genomic context of bla NDM-1 in PIMB10EC27 more complex with 6 resistance genes, including adh, glo, fgh, bla NDM-1 , ble MBL , and bla SHV-12, which may also affect the dissemination and expression of bla NDM-1 . Further research is required to clarify these assumptions. Genome analysis was also performed to identify the genes that confer resistance to colistin of PIMB10EC27. In this research, we did not find any mcr gene that recently characterized as a novel mobile gene responsible for colistin resistance among Gram negative bacteria. 32 In addition, our transformation experiments revealed that none of the plasmids of PIMB10EC27 was associated with colistin resistance (data not shown). In another context, encoding genes involved in the attachment of L-Ara-4N and P-EtN to LPSs of PIMB10EC27, including phoP, phoQ, pmrB, pmrA, pmrC, mgrB, lpx, and arn were examined, and amino acid replacements G273D in PmrB and F515S in PmrC of PIMB10EC27 were recorded. The role of these mutations in colistin resistance remains to be investigated. In summary, we successfully constructed the complete genome of multidrug-resistant E. cloacae strain PIMB10EC27 carrying the novel genomic context of bla NDM-1 . To our knowledge, this is the first report in Vietnam of a carbapenemase-producing E. cloacae strain that was also resistant to colistin. PIMB10EC27 was isolated from a patient not being treated with colistin and not identified as a case of a plasmid-mediated colistin-resistance mechanism.
In the battle against multidrug-resistant bacteria, particularly carbapenem-resistant bacteria, colistin has been considered to remain effective. In such context, this report of a clinical isolate that is resistant to both colistin and carbapenem raises a high concern over future clinical management and infection control.
Nucleotide sequence accession numbers. The complete nucleotide sequences of PIMB10EC27 have been deposited in GenBank under accession numbers CP020089-CP020091.
(https://www.ncbi.nlm.nih.gov/nuccore/CP020089.1/, https://www.ncbi.nlm.nih.gov/nuccore/CP020090, https:// www.ncbi.nlm.nih.gov/nuccore/CP020091).
Abbreviation list
MIC, minimum inhibitory concentration; E. cloacae, Enterobacter cloacae; CLSI, Clinical and Laboratory Standards Institute; NDM-1, New Delhi metallo-β-lactamase 1; ORF, Open Reading Frame.
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